Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide that acts as a non-selective melanocortin receptor agonist. It serves as a key research tool for studying neurochemical signaling pathways and interactions with MC3R and MC4R receptors.
Specifications and Compliance:
Form: 10 mg and 20 mg vials of lyophilized powder.
Purity: Certified ≥ 99% (accompanied by a lot-specific Certificate of Analysis / COA).
Packaging: Compliant with laboratory experimental standards.
Regulatory Warning: Compound strictly reserved for in vitro research and scientific laboratory work. It is not intended for human consumption, injection, or medical use. Handling and storage must adhere to established safety protocols and applicable local regulations.
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide that acts as a non-selective melanocortin receptor agonist. It serves as a key research tool for studying neurochemical signaling pathways and interactions with MC3R and MC4R receptors.
Specifications and Compliance:
Form: 10 mg and 20 mg vials of lyophilized powder.
Purity: Certified ≥ 99% (accompanied by a lot-specific Certificate of Analysis / COA).
Packaging: Compliant with laboratory experimental standards.
Regulatory Warning: Compound strictly reserved for in vitro research and scientific laboratory work. It is not intended for human consumption, injection, or medical use. Handling and storage must adhere to established safety protocols and applicable local regulations.